Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Investor Network Invites You to the DarioHealth First Quarter 2017 Earnings Conference Call and Webcast Live on Monday, May 15, 2017

DRIO

CAESAREA, ISRAEL / ACCESSWIRE / May 12, 2017 / DarioHealth Corp. (NASDAQ: DRIO) will host a conference call and live webcast to discuss the results of first quarter 2017, to be held Monday, May 15, 2017 at 9:00 AM Eastern Time.

Live Event Information

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

- Date, Time: May 15, 2017 at 9:00 AM ET - Toll Free: (866) 682-6100 - International: (862) 255-5401 - Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175941

Replay Information

The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on May 29, 2017.

- Toll Free: 877-481-4010 - International: 919-882-2331 - Replay ID#: 10384 - Webcast: www.investorcalendar.com

About DarioHealth Corp.

DarioHealth Corp. (DRIO) is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. For more information, visit http://mydario.investorroom.com/.

SOURCE: Investor Network



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today